Cannabinoid-2 receptor activation ameliorates hepatorenal syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cannabinoid-2 receptor activation ameliorates hepatorenal syndrome

Published:2020-05 Issue: Volume:152 Page:540-550
ISSN:0891-5849
Container-title:Free Radical Biology and Medicine
language:en
Short-container-title:Free Radical Biology and Medicine

Author:

Trojnar Eszter,Erdelyi Katalin,Matyas Csaba,Zhao Suxian,Paloczi Janos,Mukhopadhyay Partha,Varga Zoltan V.,Hasko Gyorgy,Pacher Pal

Funder

NIH/NIAAA

Rosztoczy Foundation

Human Capacities Grant Management Office

Hungarian Ministry of Human Capacities

Publisher

Elsevier BV

Subject

Physiology (medical),Biochemistry

Reference53 articles.

1. Acute kidney injury and hepatorenal syndrome in cirrhosis;Egerod Israelsen;J. Gastroenterol. Hepatol.,2015

2. Acute kidney injury in acute-on-chronic liver failure: where does hepatorenal syndrome fit?;Davenport;Kidney Int.,2017

3. Updates on hepato-renal syndrome;Fukazawa;J. Anesth. Clin. Res.,2013

4. Renal failure and cirrhosis: a systematic review of mortality and prognosis;Fede;J. Hepatol.,2012

5. Dithiothreitol supplementation mitigates hepatic and renal injury in bile duct ligated mice: potential application in the treatment of cholestasis-associated complications;Heidari;Biomed. Pharmacother.,2018

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of the CB2 Cannabinoid Receptor in Inflammatory Diseases: An Update;Molecules;2024-07-18

2. A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for In Vivo Studies;ACS Pharmacology & Translational Science;2024-07-09

3. Patent review of cannabinoid receptor type 2 (CB ₂ R) modulators (2016-present);Expert Opinion on Therapeutic Patents;2024-07-02

4. A highly potent, orally bioavailable pyrazole-derived cannabinoid CB2 receptor-selective full agonist forin vivostudies;2024-04-29

5. Pathophysiology of Hepatorenal Syndrome;Advances in Kidney Disease and Health;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3